"Antimutagenic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that reduce the frequency or rate of spontaneous or induced mutations independently of the mechanism involved.
| Descriptor ID |
D016587
|
| MeSH Number(s) |
D27.505.696.706.080 D27.720.799.042
|
| Concept/Terms |
Antimutagenic Agents- Antimutagenic Agents
- Agents, Antimutagenic
- Antimutagens
- Anti-Mutagenic Agents
- Agents, Anti-Mutagenic
- Anti Mutagenic Agents
Antimutagenic Effect- Antimutagenic Effect
- Effect, Antimutagenic
- Anti-Mutagenic Effects
- Anti Mutagenic Effects
- Effects, Anti-Mutagenic
- Antimutagenic Effects
- Effects, Antimutagenic
- Anti-Mutagenic Effect
- Anti Mutagenic Effect
- Effect, Anti-Mutagenic
|
Below are MeSH descriptors whose meaning is more general than "Antimutagenic Agents".
Below are MeSH descriptors whose meaning is more specific than "Antimutagenic Agents".
This graph shows the total number of publications written about "Antimutagenic Agents" by people in this website by year, and whether "Antimutagenic Agents" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Antimutagenic Agents" by people in Profiles.
-
Benign prostatic hyperplasia. Part 2--management. BMJ. 2008 Jan 26; 336(7637):206-10.
-
Anticlastogenic potential of 1alpha,25-dihydroxyvitamin D3 in murine lymphoma. Cancer Lett. 2000 Mar 13; 150(1):1-13.
-
Multiple antimutagenesis mechanisms affect mutagenic activity and specificity of the base analog 6-N-hydroxylaminopurine in bacteria and yeast. Mutat Res. 1998 Jun 18; 402(1-2):41-50.
-
Development of new cancer chemoprevention agents: role of pharmacokinetic/pharmacodynamic and intermediate endpoint biomarker monitoring. Clin Chem. 1998 Feb; 44(2):420-7.
-
In vitro protective effects of chemopreventive agents against bleomycin-induced genotoxicity in lymphoblastoid cell lines and peripheral blood lymphocytes of head and neck cancer patients. Cancer Detect Prev. 1993; 17(6):575-83.
-
Anticlastogenic effects of 13-cis-retinoic acid in vitro. Eur J Cancer. 1992; 29A(1):137-40.